Rapid Market Capitalization from 2010 to 2024
| RPID Stock | USD 1.11 0.03 2.78% |
Check Rapid Micro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rapid Micro's main balance sheet or income statement drivers, such as Interest Expense of 1.9 M, Selling General Administrative of 14.6 M or Total Revenue of 19.3 M, as well as many indicators such as Price To Sales Ratio of 1.34, Dividend Yield of 0.0 or PTB Ratio of 0.28. Rapid financial statements analysis is a perfect complement when working with Rapid Micro Valuation or Volatility modules.
Rapid | Market Capitalization |
Latest Rapid Micro's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Rapid Micro Biosystems over the last few years. It is Rapid Micro's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rapid Micro's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 47.77 M | 10 Years Trend |
|
Market Cap |
| Timeline |
Rapid Market Capitalization Regression Statistics
| Arithmetic Mean | 657,746,155 | |
| Geometric Mean | 430,843,009 | |
| Coefficient Of Variation | 51.36 | |
| Mean Deviation | 277,295,216 | |
| Median | 848,737,075 | |
| Standard Deviation | 337,833,017 | |
| Sample Variance | 114131.1T | |
| Range | 818.5M | |
| R-Value | (0.77) | |
| Mean Square Error | 49665T | |
| R-Squared | 0.60 | |
| Significance | 0.0007 | |
| Slope | (58,315,375) | |
| Total Sum of Squares | 1597836.1T |
Rapid Market Capitalization History
About Rapid Micro Financial Statements
Rapid Micro stakeholders use historical fundamental indicators, such as Rapid Micro's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Rapid Micro investors may analyze each financial statement separately, they are all interrelated. For example, changes in Rapid Micro's assets and liabilities are reflected in the revenues and expenses on Rapid Micro's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Rapid Micro Biosystems. Please read more on our technical analysis and fundamental analysis pages.
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts. Rapid Micro operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 202 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Rapid Micro Biosystems is a strong investment it is important to analyze Rapid Micro's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Rapid Micro's future performance. For an informed investment choice regarding Rapid Stock, refer to the following important reports:Check out the analysis of Rapid Micro Correlation against competitors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rapid Micro. If investors know Rapid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rapid Micro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.12) | Revenue Per Share 0.603 | Quarterly Revenue Growth 0.237 | Return On Assets (0.25) | Return On Equity (0.46) |
The market value of Rapid Micro Biosystems is measured differently than its book value, which is the value of Rapid that is recorded on the company's balance sheet. Investors also form their own opinion of Rapid Micro's value that differs from its market value or its book value, called intrinsic value, which is Rapid Micro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rapid Micro's market value can be influenced by many factors that don't directly affect Rapid Micro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rapid Micro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rapid Micro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rapid Micro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.